(HAG) Hensoldt - Overview
Stock: Radar Systems, Optronics, Electronic Warfare, IFF Systems, Air Traffic Control
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.56% |
| Yield on Cost 5y | 3.60% |
| Yield CAGR 5y | 40.04% |
| Payout Consistency | 100.0% |
| Payout Ratio | 46.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.0% |
| Relative Tail Risk | -4.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.46 |
| Alpha | 112.08 |
| Character TTM | |
|---|---|
| Beta | -0.065 |
| Beta Downside | 0.208 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.83% |
| CAGR/Max DD | 0.98 |
Description: HAG Hensoldt January 04, 2026
Hensoldt AG (XETRA:HAG) supplies a broad portfolio of sensor and optronic solutions for defense and security markets worldwide, organized into Sensors and Optronics segments. Its product line spans mobile and stationary radars, IFF (identification-friend-or-foe) systems, secure data links, electronic warfare suites, cyber-defence tools, mission computers, flight data recorders, and a range of electro-optical devices such as rifle scopes, night-vision and thermal imaging cameras.
Beyond core defense hardware, the company offers ancillary services including system integration, maintenance, training, simulation, and space-based sensor components. It also provides civil-aviation infrastructure such as air-traffic-control radars, weather radars, runway lighting, and related software, positioning Hensoldt as a cross-sector supplier for both military and civilian customers.
Key financial and market indicators (as of FY 2023) show revenue of roughly €1.3 billion, an operating margin near 10 %, and a backlog that grew about 12 % year-on-year, reflecting rising demand from NATO members as defense budgets in Europe rise by an average of 5 % annually. The firm’s exposure to semiconductor supply constraints and the broader shift toward network-centric warfare are material risk factors that could affect future earnings.
For a deeper quantitative view, you might explore Hensoldt’s profile on ValueRay, where detailed financial metrics and analyst forecasts are compiled.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 124.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.30 > 1.0 |
| NWC/Revenue: 18.71% < 20% (prev 20.51%; Δ -1.80% < -1%) |
| CFO/TA 0.08 > 3% & CFO 394.0m > Net Income 124.0m |
| Net Debt (1.09b) to EBITDA (388.0m): 2.81 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 21.46% > 18% (prev 0.22%; Δ 2123 % > 0.5%) |
| Asset Turnover: 51.38% > 50% (prev 47.78%; Δ 3.60% > 0%) |
| Interest Coverage Ratio: 1.93 > 6 (EBITDA TTM 388.0m / Interest Expense TTM 106.0m) |
Altman Z'' 1.12
| A: 0.09 (Total Current Assets 2.48b - Total Current Liabilities 2.03b) / Total Assets 4.97b |
| B: 0.04 (Retained Earnings 191.0m / Total Assets 4.97b) |
| C: 0.04 (EBIT TTM 205.0m / Avg Total Assets 4.67b) |
| D: 0.10 (Book Value of Equity 404.0m / Total Liabilities 4.12b) |
| Altman-Z'' Score: 1.12 = BB |
Beneish M -3.02
| DSRI: 0.97 (Receivables 858.0m/770.0m, Revenue 2.40b/2.09b) |
| GMI: 1.04 (GM 21.46% / 22.38%) |
| AQI: 0.90 (AQ_t 0.38 / AQ_t-1 0.42) |
| SGI: 1.15 (Revenue 2.40b / 2.09b) |
| TATA: -0.05 (NI 124.0m - CFO 394.0m) / TA 4.97b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of HAG shares?
Over the past week, the price has changed by -2.08%, over one month by -9.96%, over three months by -18.16% and over the past year by +115.55%.
Is HAG a buy, sell or hold?
What are the forecasts/targets for the HAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.1 | 17.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 105.6 | 35.8% |
HAG Fundamental Data Overview February 03, 2026
P/E Trailing = 78.1776
P/E Forward = 64.1026
P/S = 4.0273
P/B = 11.5843
P/EG = 2.0451
Revenue TTM = 2.40b EUR
EBIT TTM = 205.0m EUR
EBITDA TTM = 388.0m EUR
Long Term Debt = 1.16b EUR (from longTermDebt, last quarter)
Short Term Debt = 46.0m EUR (from shortTermDebt, last quarter)
Debt = 1.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.09b EUR (from netDebt column, last quarter)
Enterprise Value = 10.72b EUR (9.66b + Debt 1.59b - CCE 532.0m)
Interest Coverage Ratio = 1.93 (Ebit TTM 205.0m / Interest Expense TTM 106.0m)
EV/FCF = 55.85x (Enterprise Value 10.72b / FCF TTM 192.0m)
FCF Yield = 1.79% (FCF TTM 192.0m / Enterprise Value 10.72b)
FCF Margin = 8.0% (FCF TTM 192.0m / Revenue TTM 2.40b)
Net Margin = 5.17% (Net Income TTM 124.0m / Revenue TTM 2.40b)
Gross Margin = 21.46% ((Revenue TTM 2.40b - Cost of Revenue TTM 1.89b) / Revenue TTM)
Gross Margin QoQ = 20.81% (prev 18.0%)
Tobins Q-Ratio = 2.16 (Enterprise Value 10.72b / Total Assets 4.97b)
Interest Expense / Debt = 1.32% (Interest Expense 21.0m / Debt 1.59b)
Taxrate = 10.26% (12.0m / 117.0m)
NOPAT = 184.0m (EBIT 205.0m * (1 - 10.26%))
Current Ratio = 1.22 (Total Current Assets 2.48b / Total Current Liabilities 2.03b)
Debt / Equity = 1.89 (Debt 1.59b / totalStockholderEquity, last quarter 843.0m)
Debt / EBITDA = 2.81 (Net Debt 1.09b / EBITDA 388.0m)
Debt / FCF = 5.68 (Net Debt 1.09b / FCF TTM 192.0m)
Total Stockholder Equity = 862.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.65% (Net Income 124.0m / Total Assets 4.97b)
RoE = 14.37% (Net Income TTM 124.0m / Total Stockholder Equity 862.8m)
RoCE = 10.15% (EBIT 205.0m / Capital Employed (Equity 862.8m + L.T.Debt 1.16b))
RoIC = 9.41% (NOPAT 184.0m / Invested Capital 1.96b)
WACC = 5.04% (E(9.66b)/V(11.26b) * Re(5.68%) + D(1.59b)/V(11.26b) * Rd(1.32%) * (1-Tc(0.10)))
Discount Rate = 5.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 4.42%
[DCF Debug] Terminal Value 86.89% ; FCFF base≈142.4m ; Y1≈150.8m ; Y5≈179.1m
Fair Price DCF = 36.53 (EV 5.31b - Net Debt 1.09b = Equity 4.22b / Shares 115.5m; r=5.90% [WACC]; 5y FCF grow 6.53% → 2.90% )
EPS Correlation: -16.92 | EPS CAGR: -43.08% | SUE: -1.30 | # QB: 0
Revenue Correlation: 35.62 | Revenue CAGR: -1.46% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=1.96 | Chg30d=-0.012 | Revisions Net=+1 | Growth EPS=+20.9% | Growth Revenue=+10.7%